# Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)

Study · id `cardio:ct-nct01277822` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01277822](<https://clinicaltrials.gov/study/NCT01277822>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01277822

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 334 participants.

## Technical summary

Registry record NCT01277822. Randomized; double masking; primary purpose treatment. Start 2011-05-30 (actual); primary completion 2013-04-22 (actual). Results posted on 2014-04-24.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 334 participants (enrolled count; ClinicalTrials.gov record NCT01277822, source copy `cardio:ctgov-nct01277822-2024-06-20`, retrieved 2026-10-26)
- Started: 2011-05-30 (actual) (ClinicalTrials.gov record NCT01277822, source copy `cardio:ctgov-nct01277822-2024-06-20`, retrieved 2026-10-26)
- Primary completion: 2013-04-22 (actual) (ClinicalTrials.gov record NCT01277822, source copy `cardio:ctgov-nct01277822-2024-06-20`, retrieved 2026-10-26)
- Completion: 2013-04-22 (actual) (ClinicalTrials.gov record NCT01277822, source copy `cardio:ctgov-nct01277822-2024-06-20`, retrieved 2026-10-26)
- Results first posted: 2014-04-24 (ClinicalTrials.gov record NCT01277822, source copy `cardio:ctgov-nct01277822-2024-06-20`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01277822-2024-06-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)
- Condition: Hypertension
- Intervention (Drug): Losartan (+) amlodipine
- Intervention (Drug): Placebo to match losartan/amlodipine tablets
- Intervention (Drug): Amlodipine camsylate
- Intervention (Drug): Placebo to match amlodipine
- Lead sponsor: Organon and Co
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Organon and Co (`cardio:org-organon-and-co`)

## Provenance

Content hash: 92a1389efc12daad1cfbe1d529b57638aae7d5faae986f85954026b6649c36eb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
